IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
Jan 08, 2023 5:00pm EST

IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S

Dec 20, 2022 12:37pm EST

IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Dec 16, 2022 8:00am EST

IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Dec 15, 2022 7:05am EST

IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL

Dec 13, 2022 7:05am EST

IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split

Dec 07, 2022 4:05pm EST

IMV Shareholders Approve Reverse Stock Split at 88%

Nov 25, 2022 4:05pm EST

IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities

Nov 10, 2022 4:05pm EST

IMV Inc. Announces Third Quarter 2022 Financial and Operational Results

Nov 08, 2022 7:05am EST

IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022

Sep 30, 2022 7:05am EDT

IMV Provides an Update on The VITALIZE Trial

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...42
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2023 IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap